Schedule 13G ownership disclosure
VISTAGEN THERAPEUTICS INC
Security class unavailable · CUSIP: 92840H202
Event date: 2016-02-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013594-16-000852
- Form type
- SC 13G
- Filer
- NEXTHERA CAPITAL LP
- CIK
- CIK 1646343
- Filed
- Feb 29, 2016
- Reporting period
- Feb 19, 2016
- Description
- Schedule 13G beneficial ownership